[go: up one dir, main page]

CN110835530A - Reversible light modulation and control fluorescent liquid crystal nano particle and reversible light modulation and control color fluorescent ink - Google Patents

Reversible light modulation and control fluorescent liquid crystal nano particle and reversible light modulation and control color fluorescent ink Download PDF

Info

Publication number
CN110835530A
CN110835530A CN201810930147.9A CN201810930147A CN110835530A CN 110835530 A CN110835530 A CN 110835530A CN 201810930147 A CN201810930147 A CN 201810930147A CN 110835530 A CN110835530 A CN 110835530A
Authority
CN
China
Prior art keywords
compound
liquid crystal
organic solvent
reversible light
contact reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810930147.9A
Other languages
Chinese (zh)
Other versions
CN110835530B (en
Inventor
郭金宝
李洁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing University of Chemical Technology
Original Assignee
Beijing University of Chemical Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing University of Chemical Technology filed Critical Beijing University of Chemical Technology
Priority to CN201810930147.9A priority Critical patent/CN110835530B/en
Publication of CN110835530A publication Critical patent/CN110835530A/en
Application granted granted Critical
Publication of CN110835530B publication Critical patent/CN110835530B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/37Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by etherified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • C07D279/22[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/12Esters of monohydric alcohols or phenols
    • C08F220/16Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms
    • C08F220/18Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms with acrylic or methacrylic acids
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D11/00Inks
    • C09D11/50Sympathetic, colour changing or similar inks
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/38Polymers
    • C09K19/3833Polymers with mesogenic groups in the side chain
    • C09K19/3842Polyvinyl derivatives
    • C09K19/3852Poly(meth)acrylate derivatives
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/14Macromolecular compounds
    • C09K2211/1408Carbocyclic compounds
    • C09K2211/1425Non-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/14Macromolecular compounds
    • C09K2211/1441Heterocyclic
    • C09K2211/145Heterocyclic containing oxygen as the only heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/14Macromolecular compounds
    • C09K2211/1441Heterocyclic
    • C09K2211/1458Heterocyclic containing sulfur as the only heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/14Macromolecular compounds
    • C09K2211/1441Heterocyclic
    • C09K2211/1483Heterocyclic containing nitrogen and sulfur as heteroatoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02BCLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO BUILDINGS, e.g. HOUSING, HOUSE APPLIANCES OR RELATED END-USER APPLICATIONS
    • Y02B20/00Energy efficient lighting technologies, e.g. halogen lamps or gas discharge lamps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

本发明公开了一种可逆光调控荧光液晶纳米粒子及可逆光调控彩色荧光墨水,该可逆光调控荧光液晶纳米粒子通过细乳液聚合法制得,包括在第一有机溶剂的存在下,将氰芪结构单体、向列相液晶单体和二芳基乙烯类化合物混合均匀,得到液晶混合物;将热引发剂、稳定剂和所述液晶混合物混合得到油相,将乳化剂和水混合得到水相,将油相和水相进行混合乳化,得到粗乳液;将粗乳液进行超声均质化,得到细乳液;在保护气体存在下,将细乳液除氧后进行加热聚合,得到可逆光调控荧光液晶纳米粒子;其中,氰芪结构单体如通式I所示,M1为R1、R2、R3或R4所示的基团,M2选自通式II或通式III所示的基团,n为1‑9的整数;

Figure 201810930147

The invention discloses a reversible light-adjustable fluorescent liquid crystal nanoparticle and a reversible light-adjustable color fluorescent ink. The reversible light-adjustable fluorescent liquid crystal nanoparticle is prepared by a mini-emulsion polymerization method. The monomer, the nematic liquid crystal monomer and the diarylethene compound are evenly mixed to obtain a liquid crystal mixture; the thermal initiator, the stabilizer and the liquid crystal mixture are mixed to obtain an oil phase, and the emulsifier and water are mixed to obtain a water phase, The oil phase and the water phase are mixed and emulsified to obtain a coarse emulsion; the coarse emulsion is ultrasonically homogenized to obtain a fine emulsion; in the presence of a protective gas, the small emulsion is deoxygenated and then heated and polymerized to obtain a reversible light-regulated fluorescent liquid crystal nanoparticle. particle; wherein, the cyanostilbene structural monomer is shown in general formula I, M 1 is a group represented by R 1 , R 2 , R 3 or R 4 , and M 2 is selected from general formula II or general formula III. group, n is an integer of 1-9;

Figure 201810930147

Description

可逆光调控荧光液晶纳米粒子及可逆光调控彩色荧光墨水Reversible light-tunable fluorescent liquid crystal nanoparticles and reversible light-tunable color fluorescent ink

技术领域technical field

本发明属于液晶纳米粒子材料领域,更具体地,涉及一种可逆光调控荧光液晶纳米粒子及可逆光调控彩色荧光墨水。The invention belongs to the field of liquid crystal nanoparticle materials, and more particularly relates to a reversible light-regulated fluorescent liquid crystal nanoparticle and a reversible light-regulated color fluorescent ink.

背景技术Background technique

液晶是介于液体和晶体之间的一种中间相态,通常情况下,液晶分子结构细长且具有一定刚性,这使得液晶分子的排列具有一定的指向,从而液晶兼具液体的流动性、连续性以及晶体的有序性、各向异性。由于独特的结构以及特点使液晶材料具有独特的光学性能,并且液晶分子的排列极易受到外界刺激的作用而发生改变。Liquid crystal is an intermediate phase between liquid and crystal. Usually, the liquid crystal molecular structure is slender and has a certain rigidity, which makes the arrangement of the liquid crystal molecules have a certain direction, so that the liquid crystal has both the fluidity and the liquid crystal. Continuity and order and anisotropy of crystals. Because of the unique structure and characteristics, the liquid crystal material has unique optical properties, and the arrangement of the liquid crystal molecules is easily changed by the action of external stimuli.

在特定工艺条件下,将液晶材料制备成粒径≤100nm的液晶颗粒,称作液晶纳米粒子(liquid crystal nanoparticles,LCNPs)。其具有(1)容易制备,且可以达到100nm甚至更小粒径且单分散的纳米微球结构(2)低毒性(3)稳定性好(4)在特定条件下易于被观察等特点。基于以上特点,液晶纳米粒子有望应用在药物等在生物体内的递送以及信息的储存重现及可视化等方面。Under specific process conditions, the liquid crystal material is prepared into liquid crystal particles with a particle size of less than or equal to 100 nm, which are called liquid crystal nanoparticles (LCNPs). It has the characteristics of (1) easy preparation, monodisperse nano-microsphere structure that can reach 100nm or even smaller particle size (2) low toxicity (3) good stability (4) easy to be observed under specific conditions and so on. Based on the above characteristics, liquid crystal nanoparticles are expected to be used in the delivery of drugs in vivo, as well as the storage, reproduction and visualization of information.

荧光材料可以广泛的应用于生产生活各个方面,例如:农业上,可以制备农用光转换膜,将不利于农作物生长的的紫外光转换成适合其生长的红橙色光,起到增加产量的效果;在工业上,可以用在防伪印刷上,在外界光刺激下,可以出现颜色的改变;在医疗方面上,可以用做生物分子的荧光标记,进而用作药物的递送等方面。不过传统有机荧光材料[1]具有荧光寿命短、易光解,易褪色,光解产物大多有毒有害等缺点,进而使它们的应用受到限制。氰芪结构的有机荧光材料是一种含有共轭结构的有机材料,具有荧光能力强,结构易修饰、光功能性质易调节、低毒环保、荧光稳定的优点,避免了一些线性有机共轭荧光材料存在的荧光淬灭效应(aggregation-caused quenching,ACQ)。含有氰基取代的二苯乙烯基衍生物称为氰芪结构或氰芪结构的衍生物,其具有一种聚集性荧光增强的特性(aggregation induced enhanced emission,AIEE),通常情况下,由于分子间存在强烈的相互作用导致大量的非辐射失活,荧光有机化合物的荧光强度在稀溶液中比在固态或聚集状态高得多,而聚集诱导增强发光(AIEE)化合物则完全相反。它们的衍生物在固态或聚集状态具有非常高的荧光量子产率。Fluorescent materials can be widely used in all aspects of production and life. For example, in agriculture, agricultural light conversion films can be prepared to convert the ultraviolet light that is not conducive to the growth of crops into red-orange light suitable for their growth, which can increase the yield; In industry, it can be used in anti-counterfeiting printing, and the color can be changed under external light stimulation; in medical treatment, it can be used as a fluorescent label for biomolecules, and then used for drug delivery. However, traditional organic fluorescent materials [1] have the disadvantages of short fluorescence lifetime, easy photolysis, easy fading, and most of the photolysis products are toxic and harmful, which limits their application. The organic fluorescent material of cyanostilbene structure is an organic material containing a conjugated structure, which has the advantages of strong fluorescence ability, easy modification of structure, easy adjustment of photofunctional properties, low toxicity and environmental protection, and stable fluorescence, avoiding some linear organic conjugated fluorescence. The presence of fluorescence quenching effect (aggregation-caused quenching, ACQ) of the material. The stilbene derivatives containing cyano group substitution are called cyanostilbene structure or cyanostilbene structure derivatives, which have a kind of aggregation induced enhanced emission (AIEE), usually due to the intermolecular structure. The presence of strong interactions results in substantial nonradiative inactivation, and the fluorescence intensity of fluorescent organic compounds is much higher in dilute solution than in the solid or aggregated state, while aggregation-induced enhanced emission (AIEE) compounds are the exact opposite. Their derivatives have very high fluorescence quantum yields in the solid or aggregated state.

1988年入江正浩等人在二苯乙烯的基础上设计合成出了具有光异构反应的二芳基乙烯类化合物。这是一类具有光异构反应的化合物。这种化合物会在光照条件下进行开闭环反应,产生同分异构体的转化,在此过程中发生分子内或分子间的能量共振转移,在光吸收性质、颜色、导电性、荧光与磷光发射等方面表现不同,不论是开环还是闭环状态下,分子都保持很好的稳定性。其有如下优点:①热稳定性好;②抗疲劳性能强,分子开闭环循环次数很高;③有快速的光响应行为,分子对光的响应在2-20ps内即可发生;④开闭环转化率高,其大多数在光作用下的开环/闭环转化率可达到100%。In 1988, Zhenghao Irie and others designed and synthesized diarylethene compounds with photoisomerization reaction on the basis of stilbene. This is a class of compounds that have photoisomerization reactions. This compound will undergo ring opening and closing reactions under light conditions, resulting in the conversion of isomers, during which intramolecular or intermolecular energy resonance transfer occurs. The emission and other aspects are different, and the molecule maintains good stability whether in the open-loop or closed-loop state. It has the following advantages: 1. Good thermal stability; 2. Strong anti-fatigue performance, and the number of molecular open and closed loop cycles is very high; 3. Fast light response behavior, and the molecular response to light can occur within 2-20ps; ④ Open and closed loops The conversion rate is high, and most of its open-loop/closed-loop conversion rates under the action of light can reach 100%.

因此,有必要提供一种荧光液晶纳米粒子。Therefore, it is necessary to provide a fluorescent liquid crystal nanoparticle.

发明内容SUMMARY OF THE INVENTION

本发明的目的是提供一种荧光液晶纳米粒子,进而提供一种能用365nm紫外-可见光进行可逆光调控的彩色荧光墨水。The purpose of the present invention is to provide a fluorescent liquid crystal nanoparticle, and further provide a color fluorescent ink that can be reversibly light-regulated with 365nm ultraviolet-visible light.

为了实现上述目的,本发明一方面提供一种可逆光调控荧光液晶纳米粒子,该可逆光调控荧光液晶纳米粒子通过细乳液聚合法制得,具体包括如下步骤:In order to achieve the above object, one aspect of the present invention provides a reversible light-regulated fluorescent liquid crystal nanoparticle, which is prepared by a mini-emulsion polymerization method, and specifically includes the following steps:

(1)在第一有机溶剂的存在下,将氰芪结构单体、向列相液晶单体和二芳基乙烯类化合物混合均匀,得到液晶混合物;(1) in the presence of the first organic solvent, uniformly mixing the cyanostilbene structural monomer, the nematic liquid crystal monomer and the diarylethene compound to obtain a liquid crystal mixture;

(2)将热引发剂、稳定剂和所述液晶混合物混合得到油相,将乳化剂和水混合得到水相,将油相和水相进行混合乳化,得到粗乳液;(2) mixing thermal initiator, stabilizer and described liquid crystal mixture to obtain oil phase, mixing emulsifier and water to obtain water phase, mixing and emulsification of oil phase and water phase to obtain coarse emulsion;

(3)将所述粗乳液进行超声均质化,得到细乳液;(3) ultrasonically homogenizing the coarse emulsion to obtain a fine emulsion;

(4)在保护气体存在下,将所述细乳液进行加热聚合,得到液晶纳米粒子;(4) in the presence of protective gas, heating and polymerizing the mini-emulsion to obtain liquid crystal nanoparticles;

其中,所述氰芪结构单体如通式I所示,M1为R1、R2、R3或R4所示的基团,M2选自通式II或通式III所示的基团,n为1-9的整数;Wherein, the cyanostilbene structural monomer is shown in general formula I, M 1 is a group represented by R 1 , R 2 , R 3 or R 4 , and M 2 is selected from general formula II or general formula III. group, n is an integer of 1-9;

Figure BDA0001766389860000031
Figure BDA0001766389860000031

本发明的另一方面提供一种可逆光调控彩色荧光墨水,以所述的可逆光调控彩色荧光墨水的总重量计,该可逆光调控彩色荧光墨水包括:3-10wt%的上述可逆光调控荧光液晶纳米粒子,2-6wt%的成膜剂,5-45wt%的水溶性有机溶剂,2-4wt%的乳化剂,0.1-2wt%的pH调节剂和0-70wt%的水,且各组分之和为100wt%。Another aspect of the present invention provides a reversible light-adjustable color fluorescent ink. Based on the total weight of the reversible light-adjustable color fluorescent ink, the reversible light-adjustable color fluorescent ink comprises: 3-10wt% of the above reversible light-adjustable fluorescent ink Liquid crystal nanoparticles, 2-6wt% film-forming agent, 5-45wt% water-soluble organic solvent, 2-4wt% emulsifier, 0.1-2wt% pH adjuster and 0-70wt% water, and each group The sum of the fractions is 100 wt%.

本发明的技术方案具有如下优点:The technical scheme of the present invention has the following advantages:

本发明提供了一类新型的可聚合氰芪结构单体,在紫外光激发下分别得到红、蓝、绿三色荧光;The invention provides a new type of polymerizable cyanostilbene structural monomer, which can obtain red, blue and green fluorescence respectively under the excitation of ultraviolet light;

本发明的荧光液晶纳米粒子在紫外光-可见光的交替照射下可进行可逆的荧光强度的调控;The fluorescent liquid crystal nanoparticles of the present invention can perform reversible regulation of fluorescence intensity under the alternating irradiation of ultraviolet light and visible light;

本发明的荧光液晶纳米粒子可制备得到彩色荧光墨水,经喷墨打印后实现写入信息的荧光影像从隐到显的可逆变化。The fluorescent liquid crystal nanoparticles of the present invention can be prepared to obtain color fluorescent ink, and after inkjet printing, the fluorescent image of the written information can be reversibly changed from hidden to obvious.

本发明的其它特征和优点将在随后具体实施方式部分予以详细说明。Other features and advantages of the present invention will be described in detail in the detailed description that follows.

附图说明Description of drawings

通过结合附图对本发明示例性实施方式进行更详细的描述,本发明的上述以及其它目的、特征和优势将变得更加明显,其中,在本发明示例性实施方式中,相同的参考标号通常代表相同部件。The above and other objects, features and advantages of the present invention will become more apparent from the more detailed description of the exemplary embodiments of the present invention in conjunction with the accompanying drawings, wherein the same reference numerals generally represent the exemplary embodiments of the present invention. same parts.

图1示出了根据本发明的一个实施例的可逆光调控荧光液晶纳米粒子的扫描电镜照片。FIG. 1 shows a scanning electron microscope photograph of a reversible light-adjustable fluorescent liquid crystal nanoparticle according to an embodiment of the present invention.

图2a示出了根据本发明的一个实施例的可逆光调控荧光液晶纳米粒子在功率为2mW的波长为365nm的UV灯照射下的荧光发射光谱随时间变化的示意图。其中,图中从上至下的曲线分别代表0s、5s、10s、15s、20s、25s、30s的下的荧光发射光谱。Fig. 2a shows a schematic diagram of the fluorescence emission spectrum of the reversible light-tunable fluorescent liquid crystal nanoparticles according to an embodiment of the present invention under the irradiation of a UV lamp with a power of 2 mW and a wavelength of 365 nm. Among them, the curves from top to bottom in the figure represent the fluorescence emission spectra at 0s, 5s, 10s, 15s, 20s, 25s, and 30s, respectively.

图2b示出了根据本发明的一个实施例的可逆光调控荧光液晶纳米粒子在可见光源照射下的荧光发射光谱随时间变化的示意图。其中,图中从下至上的曲线分别代表10s、20s、30s、40s、50s、60s、70s、80s、90s、110s的下的荧光发射光谱。Fig. 2b shows a schematic diagram of the time-dependent change of the fluorescence emission spectrum of the reversible light-adjustable fluorescent liquid crystal nanoparticles under the illumination of a visible light source according to an embodiment of the present invention. The curves from bottom to top in the figure represent the fluorescence emission spectra at 10s, 20s, 30s, 40s, 50s, 60s, 70s, 80s, 90s, and 110s, respectively.

图3示出了根据本发明的一个实施例的可逆光调控荧光液晶纳米粒子在紫外-可见光源交替照射下荧光强度极限值随时间变化的示意图。FIG. 3 is a schematic diagram showing the change of the limit value of the fluorescence intensity with time of the reversible light-tunable fluorescent liquid crystal nanoparticles under the alternating irradiation of ultraviolet-visible light sources according to an embodiment of the present invention.

图4示出了根据本发明的一个实施例的可逆光调控彩色荧光墨水用喷墨打印技术打印在打印纸上的图案在紫外-可见光交替照射下荧光强弱变化实物图。FIG. 4 shows the actual graph of the fluorescence intensity change of the pattern printed on the printing paper by the inkjet printing technology of the reversible light-adjustable color fluorescent ink according to an embodiment of the present invention under the alternating irradiation of ultraviolet-visible light.

具体实施方式Detailed ways

下面将更详细地描述本发明的优选实施方式。虽然以下描述了本发明的优选实施方式,然而应该理解,可以以各种形式实现本发明而不应被这里阐述的实施方式所限制。相反,提供这些实施方式是为了使本发明更加透彻和完整,并且能够将本发明的范围完整地传达给本领域的技术人员。Preferred embodiments of the present invention will be described in more detail below. While the preferred embodiments of the present invention are described below, it should be understood that the present invention may be embodied in various forms and should not be limited by the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the present invention to those skilled in the art.

本发明一方面提供了一种可逆光调控荧光液晶纳米粒子,该可逆光调控荧光液晶纳米粒子通过细乳液聚合法制得,具体包括如下步骤:One aspect of the present invention provides a reversible light-adjustable fluorescent liquid crystal nanoparticle, the reversible light-adjustable fluorescent liquid crystal nanoparticle is prepared by a mini-emulsion polymerization method, and specifically includes the following steps:

(1)在第一有机溶剂的存在下,将氰芪结构单体、向列相液晶单体和二芳基乙烯类化合物混合均匀,得到液晶混合物;(1) in the presence of the first organic solvent, uniformly mixing the cyanostilbene structural monomer, the nematic liquid crystal monomer and the diarylethene compound to obtain a liquid crystal mixture;

(2)将热引发剂、稳定剂和所述液晶混合物混合得到油相,将乳化剂和水混合得到水相,将油相和水相进行混合乳化,得到粗乳液;(2) mixing thermal initiator, stabilizer and described liquid crystal mixture to obtain oil phase, mixing emulsifier and water to obtain water phase, mixing and emulsification of oil phase and water phase to obtain coarse emulsion;

(3)将所述粗乳液进行超声均质化,得到细乳液;(3) ultrasonically homogenizing the coarse emulsion to obtain a fine emulsion;

(4)在保护气体存在下,将所述细乳液进行加热聚合,得到液晶纳米粒子;(4) in the presence of protective gas, heating and polymerizing the mini-emulsion to obtain liquid crystal nanoparticles;

其中,所述氰芪结构单体如通式I所示,M1为R1、R2、R3或R4所示的基团,M2选自通式II或通式III所示的基团,n为1-9的整数;Wherein, the cyanostilbene structural monomer is shown in general formula I, M 1 is a group represented by R 1 , R 2 , R 3 or R 4 , and M 2 is selected from general formula II or general formula III. group, n is an integer of 1-9;

Figure BDA0001766389860000051
Figure BDA0001766389860000051

Figure BDA0001766389860000061
Figure BDA0001766389860000061

本发明,可逆光调控荧光液晶纳米粒子通过细乳液聚合法制备得到,将所述氰芪结构单体、二芳基乙烯化合物和向列相液晶单体的组合物包入纳米粒子中。In the present invention, the reversible light-regulated fluorescent liquid crystal nanoparticles are prepared by a mini-emulsion polymerization method, and the composition of the cyanostilbene structural monomer, the diarylene compound and the nematic liquid crystal monomer is encapsulated in the nanoparticles.

本发明中,氰芪结构单体的荧光波段可以通过自身分子共轭结构、聚集状态的变化而变化,可通过分子结构设计得到宏观上不同荧光颜色的氰芪单体。In the present invention, the fluorescence band of the cyanostilbene structural monomer can be changed by the change of its own molecular conjugated structure and aggregation state, and the cyanostilbene monomers with different fluorescent colors can be obtained macroscopically through molecular structure design.

本发明中,将二芳基乙烯类化合物引入到荧光液晶纳米粒子体系中,这种化合物会在光照条件下进行开闭环反应,可通过与氰芪结构单体间能量共振转移效应(FRET)实现对荧光的可逆调控,可做为荧光分子开关,实现荧光液晶纳米粒子的可逆光调控,即通过UV-Vis光(紫外-可见光)交替照射使二芳基乙烯类化合物进行开环闭环反应,与氰芪结构单体发生能量共振转移,使荧光产生有和无的可逆变化。In the present invention, the diarylethene compound is introduced into the fluorescent liquid crystal nanoparticle system, and the compound will undergo a ring-opening and closing reaction under illumination conditions, which can be achieved by the energy resonance transfer effect (FRET) with the cyanostilbene structural monomer. The reversible regulation of fluorescence can be used as a fluorescent molecular switch to realize the reversible light regulation of fluorescent liquid crystal nanoparticles, that is, through the alternating irradiation of UV-Vis light (ultraviolet-visible light), the diarylethene compounds undergo a ring-opening and ring-closing reaction, and the Cyanostilbene structural monomer undergoes energy resonance transfer, resulting in a reversible change in fluorescence with and without it.

根据本发明,优选地,所述氰芪结构单体选自具有通式a-1、a-2、a-3、a-4、a-5所示结构的氰芪结构化合物中的一种或多种,其中,n为1-9的整数;According to the present invention, preferably, the cyanostilbene structural monomer is selected from one of the cyanostilbene structural compounds having the structures represented by the general formulas a-1, a-2, a-3, a-4, and a-5 or more, wherein, n is an integer of 1-9;

Figure BDA0001766389860000071
Figure BDA0001766389860000071

Figure BDA0001766389860000081
Figure BDA0001766389860000081

根据本发明,优选地,所述氰芪结构单体的制备方法选自第一制备方法、第二制备方法或第三制备方法;According to the present invention, preferably, the preparation method of the cyanostilbene structural monomer is selected from the first preparation method, the second preparation method or the third preparation method;

其中,所述第一制备方法包括如下步骤:Wherein, the first preparation method comprises the following steps:

(1)在第二有机溶剂、第一碱性调节剂和第一催化剂的存在下,将化合物Ⅰ和化合物Ⅱ进行接触反应,得到化合物III;(1) in the presence of the second organic solvent, the first basic regulator and the first catalyst, the compound I and the compound II are subjected to a contact reaction to obtain the compound III;

(2)在第三有机溶剂和第二碱性调节剂的存在下,将所述化合物III和化合物Ⅳ进行接触反应,蒸除溶剂后得到化合物V;(2) in the presence of the third organic solvent and the second basic regulator, the compound III and the compound IV are subjected to a contact reaction, and the compound V is obtained after the solvent is evaporated;

(3)在第四有机溶剂和缚酸剂存在下,将所述化合物V和丙烯酰氯进行接触反应,制得所述氰芪结构单体;(3) in the presence of a fourth organic solvent and an acid binding agent, the compound V and acryloyl chloride are subjected to a contact reaction to obtain the cyanostilbene structural monomer;

所述第二制备方法包括如下步骤:The second preparation method comprises the following steps:

(1)在第五有机溶剂和第三碱性调节剂存在下,将所述化合物Ⅵ和化合物Ⅶ进行接触反应,得到化合物Ⅷ;(1) in the presence of the fifth organic solvent and the third basic regulator, the compound VI and the compound VII are subjected to a contact reaction to obtain the compound VIII;

(2)在第六有机溶剂和第二催化剂存在下,将所述化合物Ⅷ和DMF进行接触反应,得到化合物Ⅸ;(2) in the presence of the sixth organic solvent and the second catalyst, the compound VIII and DMF are subjected to a contact reaction to obtain compound IX;

(3)在第七有机溶剂存在下,将所述化合物Ⅹ与NBS进行接触反应,得到化合物Ⅺ;(3) in the presence of the seventh organic solvent, the compound X is contacted and reacted with NBS to obtain compound XI;

(4)在第八有机溶剂、第九有机溶剂、第三催化剂和Na2CO3水溶液存在下,将所述化合物Ⅺ和化合物Ⅻ进行接触反应,得到化合物ⅩⅢ;(4) in the presence of the eighth organic solvent, the ninth organic solvent, the third catalyst and the Na2CO3 aqueous solution, the compound XI and the compound XII are subjected to a contact reaction to obtain the compound XIII;

(5)在第二有机溶剂、第一碱性调节剂和第一催化剂的存在下,将化合物ⅩⅢ和化合物Ⅱ进行接触反应,得到化合物ⅩⅣ;(5) in the presence of the second organic solvent, the first basic regulator and the first catalyst, the compound XIII and the compound II are subjected to a contact reaction to obtain the compound XIV;

(6)在第三有机溶剂和第二碱性调节剂存在下,将所述化合物ⅩⅣ和化合物Ⅸ进行接触反应,蒸除溶剂后得到化合物ⅩⅤ;(6) in the presence of the third organic solvent and the second basic regulator, the compound XIV and the compound IX are subjected to a contact reaction, and the compound XV is obtained after the solvent is evaporated;

(7)在第四有机溶剂和缚酸剂存在下,将所述化合物ⅩⅤ和丙烯酰氯进行接触反应,制得所述氰芪结构单体;(7) in the presence of a fourth organic solvent and an acid binding agent, the compound XV and acryloyl chloride are subjected to a contact reaction to obtain the cyanostilbene structural monomer;

所述第三制备方法包括如下步骤:The third preparation method comprises the following steps:

(1)在第七有机溶剂存在下,将所述化合物Ⅹ与NBS进行接触反应,得到化合物Ⅺ;(1) in the presence of the seventh organic solvent, the compound X is contacted and reacted with NBS to obtain compound XI;

(2)在第八有机溶剂、第九有机溶剂、第三催化剂和Na2CO3水溶液存在下,将所述化合物Ⅺ和化合物Ⅻ进行接触反应,得到化合物ⅩⅢ;(2) in the presence of the eighth organic solvent, the ninth organic solvent, the third catalyst and the Na 2 CO 3 aqueous solution, the compound XI and the compound XII are subjected to a contact reaction to obtain the compound XIII;

(3)在第二有机溶剂、第一碱性调节剂和第一催化剂存在下,将化合物ⅩⅢ和化合物Ⅱ进行接触反应,得到化合物ⅩⅣ;(3) in the presence of the second organic solvent, the first basic regulator and the first catalyst, the compound XIII and the compound II are subjected to a contact reaction to obtain the compound XIV;

(4)在第三有机溶剂和第二碱性调节剂存在下,将所述化合物ⅩⅣ和化合物Ⅳ进行接触反应,蒸除溶剂后得到化合物ⅩⅥ;(4) in the presence of the third organic solvent and the second basic regulator, the compound XIV and the compound IV are subjected to a contact reaction, and the compound XVI is obtained after the solvent is evaporated;

(5)在第四有机溶剂和缚酸剂存在下,将所述化合物ⅩⅥ和丙烯酰氯进行接触反应,制得所述氰芪结构单体;(5) in the presence of a fourth organic solvent and an acid binding agent, the compound XVI and acryloyl chloride are subjected to a contact reaction to obtain the cyanostilbene structural monomer;

所述化合物Ⅰ的结构式为:The structural formula of the compound I is:

Figure BDA0001766389860000091
Figure BDA0001766389860000091

所述化合物II的结构式为:The structural formula of the compound II is:

Figure BDA0001766389860000092
式中,n为1-9的整数,X选自溴原子或碘原子;
Figure BDA0001766389860000092
In the formula, n is an integer of 1-9, and X is selected from a bromine atom or an iodine atom;

所述化合物III的结构式为The structural formula of the compound III is

式中,n为1-9的整数; In the formula, n is an integer from 1 to 9;

所述化合物IV的结构式为:The structural formula of the compound IV is:

Figure BDA0001766389860000094
其中,R选自所述R1、R2、R3或R4所示的结构基团,
Figure BDA0001766389860000094
wherein, R is selected from the structural groups represented by the R 1 , R 2 , R 3 or R 4 ,

所述化合物V的结构式为:The structural formula of the compound V is:

式中,n为1-9的整数;所述化合物Ⅵ的结构式为:

Figure BDA0001766389860000102
In the formula, n is an integer of 1-9; the structural formula of the compound VI is:
Figure BDA0001766389860000102

所述化合物Ⅶ的结构式为:

Figure BDA0001766389860000103
The structural formula of the compound VII is:
Figure BDA0001766389860000103

所述化合物Ⅷ的结构式为:

Figure BDA0001766389860000104
The structural formula of the compound VIII is:
Figure BDA0001766389860000104

所述化合物Ⅸ的结构式为:

Figure BDA0001766389860000105
The structural formula of the compound IX is:
Figure BDA0001766389860000105

所述化合物Ⅹ的结构式为:

Figure BDA0001766389860000106
The structural formula of the compound X is:
Figure BDA0001766389860000106

所述化合物Ⅺ的结构式为: The structural formula of the compound XI is:

所述化合物Ⅻ的结构式为:

Figure BDA0001766389860000108
The structural formula of the compound XII is:
Figure BDA0001766389860000108

所述化合物ⅩⅢ的结构式为:

Figure BDA0001766389860000111
The structural formula of the compound XIII is:
Figure BDA0001766389860000111

所述化合物ⅩⅣ的结构式为:

Figure BDA0001766389860000112
式中,n为1-9的整数;The structural formula of the compound XIV is:
Figure BDA0001766389860000112
In the formula, n is an integer from 1 to 9;

所述化合物ⅩⅤ的结构式为:The structural formula of the compound XV is:

Figure BDA0001766389860000113
式中,n为1-9的整数。
Figure BDA0001766389860000113
In the formula, n is an integer of 1-9.

所述化合物ⅩⅥ的结构式为:The structural formula of the compound XVI is:

Figure BDA0001766389860000114
式中,n为1-9的整数。
Figure BDA0001766389860000114
In the formula, n is an integer of 1-9.

根据本发明,优选地,According to the present invention, preferably,

所述第一制备方法中各步骤的反应条件包括如下:The reaction conditions of each step in the first preparation method include the following:

步骤(1)中:所述第一碱性调节剂为无水碳酸钾,所述第一催化剂为碘化钾;所述化合物Ⅰ、化合物Ⅱ、无水碳酸钾和碘化钾的摩尔比为1:3-10:3-10:0.1-1,所述第二有机溶剂为极性有机溶剂,所述第二有机溶剂优选为二甲基甲酰胺、乙腈、四氢呋喃和丙酮中的至少一种,进一步优选为丙酮;所述接触反应的温度为30-80℃,时间为12-24h;作为一种优选方案,反应结束后,可通过水洗,分液,蒸除有机相溶剂后通过柱层析纯化得到化合物III;In step (1): the first alkaline regulator is anhydrous potassium carbonate, and the first catalyst is potassium iodide; the mol ratio of the compound I, compound II, anhydrous potassium carbonate and potassium iodide is 1:3- 10:3-10:0.1-1, the second organic solvent is a polar organic solvent, the second organic solvent is preferably at least one of dimethylformamide, acetonitrile, tetrahydrofuran and acetone, more preferably Acetone; the temperature of the contact reaction is 30-80 °C, and the time is 12-24 h; as a preferred solution, after the reaction is completed, the compound can be obtained by washing with water, separating liquids, evaporating the organic phase solvent, and then purifying by column chromatography III;

步骤(2)中:所述第二碱性调节剂为叔丁醇钾;所述化合物III、化合物Ⅳ与叔丁醇钾的摩尔比为2-3:1:0.1-0.5,所述接触反应的温度为30-80℃,时间为2-8h;作为一种优选方案,反应结束后,加入盐酸进行中和,使体系变为酸性,抽滤、清洗、干燥,得到化合物V;所述第三有机溶剂为乙醇;In step (2): the second alkaline regulator is potassium tert-butoxide; the molar ratio of compound III, compound IV and potassium tert-butoxide is 2-3:1:0.1-0.5, and the contact reaction The temperature is 30-80°C, and the time is 2-8h; as a preferred solution, after the reaction is completed, add hydrochloric acid for neutralization to make the system acidic, suction filtration, cleaning, and drying to obtain compound V; Three organic solvents are ethanol;

步骤(3)中:所述缚酸剂为三乙胺;所述化合物V、丙烯酰氯和三乙胺的摩尔比为1:3-4:3-5,所述接触反应的温度为0-40℃,时间为12-24h;作为一种优选方案,反应结束后,加水淬灭反应、分液干燥、蒸除有机相溶剂后通过柱层析纯化得到所述氰芪结构单体;所述第四有机溶剂为三氯甲烷;In step (3): the acid binding agent is triethylamine; the molar ratio of the compound V, acryloyl chloride and triethylamine is 1:3-4:3-5, and the temperature of the contact reaction is 0- 40 ℃, time is 12-24h; as a preferred solution, after the reaction is completed, add water to quench the reaction, separate and dry, evaporate the organic phase solvent, and then purify by column chromatography to obtain the cyanostilbene structural monomer; the The fourth organic solvent is chloroform;

所述第二制备方法中各步骤的反应条件包括如下:The reaction conditions of each step in the second preparation method include the following:

步骤(1)中:所述第三碱性调节剂为NaH或者NaOH;所述化合物Ⅵ、化合物Ⅶ和所述第三碱性调节剂的摩尔比为1:1-3:1-10,所述接触反应的温度为0-40℃,时间为1-2小时;作为优选方案,所述第五有机溶剂为二甲基亚砜;优选地,反应结束后可通过水洗,分液,蒸除有机相溶剂后通过柱层析纯化得到化合物Ⅷ;In step (1): the third alkaline regulator is NaH or NaOH; the molar ratio of the compound VI, the compound VII and the third alkaline regulator is 1:1-3:1-10, so the The temperature of the contact reaction is 0-40 ° C, and the time is 1-2 hours; as a preferred solution, the fifth organic solvent is dimethyl sulfoxide; The organic phase solvent is then purified by column chromatography to obtain compound VIII;

步骤(2)中:所述化合物Ⅷ、DMF和第二催化剂的摩尔比为1:2-5:0.1-1所述第一催化剂为POCl3,所述接触反应的温度为30-70℃,时间为12-24h;作为优选方案,反应结束后,可通过水洗,分液,蒸除有机相溶剂后通过柱层析纯化得到化合物Ⅸ;所述第六有机溶剂为二氯甲烷;In step (2): the molar ratio of the compound VIII, DMF and the second catalyst is 1:2-5:0.1-1, the first catalyst is POCl , the temperature of the contact reaction is 30-70 ° C, and the time It is 12-24h; as a preferred solution, after the reaction is completed, compound IX can be obtained by washing with water, separating liquids, evaporating the organic phase solvent, and purifying by column chromatography; the sixth organic solvent is dichloromethane;

步骤(3)中:所述化合物Ⅹ与NBS的摩尔比为1:1-3,所述接触反应的温度为0-40℃,时间为1-5h;优选地,所述第七有机溶剂为N,N-二甲基甲酰胺;In step (3): the molar ratio of the compound X to NBS is 1:1-3, the temperature of the contact reaction is 0-40°C, and the time is 1-5h; preferably, the seventh organic solvent is N,N-dimethylformamide;

步骤(4)中:所述化合物Ⅺ、化合物Ⅻ和第二催化剂的摩尔比为1:1-3:0.1-1,所述Na2CO3水溶液的质量分数为10-30%;作为优选方案,所述第二催化剂优选为四三苯基膦钯;优选地,所述第八有机溶剂为四氢呋喃,所述第九有机溶剂为甲醇;In step (4): the molar ratio of the compound XI, the compound XII and the second catalyst is 1:1-3:0.1-1, and the mass fraction of the Na2CO3 aqueous solution is 10-30%; The second catalyst is preferably tetrakistriphenylphosphine palladium; preferably, the eighth organic solvent is tetrahydrofuran, and the ninth organic solvent is methanol;

步骤(5)包括:所述第一碱性调节剂为无水碳酸钾,所述第一催化剂为碘化钾;化合物ⅩⅢ、化合物Ⅱ、无水碳酸钾和碘化钾的摩尔比为1:3-10:3-10:0.1-1,所述第二有机溶剂为极性有机溶剂,优选为二甲基甲酰胺、乙腈、四氢呋喃和丙酮中的至少一种,进一步优选为丙酮;所述接触反应的温度为30-80℃,时间为12-24h;作为优选方案,反应结束后,可通过水洗,分液,蒸除有机相溶剂后通过柱层析纯化得到化合物ⅩⅣ;Step (5) includes: the first alkaline regulator is anhydrous potassium carbonate, and the first catalyst is potassium iodide; the mol ratio of compound XIII, compound II, anhydrous potassium carbonate and potassium iodide is 1:3-10: 3-10: 0.1-1, the second organic solvent is a polar organic solvent, preferably at least one of dimethylformamide, acetonitrile, tetrahydrofuran and acetone, more preferably acetone; the temperature of the contact reaction The temperature is 30-80°C, and the time is 12-24h; as a preferred solution, after the reaction is completed, compound XIV can be obtained by washing with water, separating liquids, evaporating the organic phase solvent, and purifying by column chromatography;

步骤(6)包括:所述第二碱性调节剂为叔丁醇钾;所述化合物ⅩⅣ、化合物Ⅸ与叔丁醇钾的摩尔比2-4:1:0.2-1,所述接触反应的温度为30-80℃,时间为2-8小时;作为优选方案,反应结束后,加入盐酸进行中和,使体系变为酸性,抽滤、清洗、干燥,得到化合物ⅩⅤ;所述第三有机溶剂为乙醇;Step (6) includes: the second alkaline regulator is potassium tert-butoxide; the molar ratio of compound XIV, compound IX and potassium tert-butoxide is 2-4:1:0.2-1, and the contact reaction is 2-4:1:0.2-1. The temperature is 30-80°C, and the time is 2-8 hours; as a preferred solution, after the reaction is completed, add hydrochloric acid for neutralization to make the system acidic, suction filtration, cleaning and drying to obtain compound XV; the third organic The solvent is ethanol;

步骤(7)包括:所述第三碱性调节剂为三乙胺;述化合物ⅩV、丙烯酰氯和三乙胺的摩尔比为1:3-4:3-5,所述接触反应的温度为0-40℃,时间为12-24h。作为优选方案,反应结束后,加水淬灭反应、分液干燥、蒸除有机相溶剂后通过柱层析纯化得到所述氰芪结构单体;所述第四有机溶剂为三氯甲烷;Step (7) includes: the third alkaline regulator is triethylamine; the molar ratio of the compound XV, acryloyl chloride and triethylamine is 1:3-4:3-5, and the temperature of the contact reaction is 0-40℃, the time is 12-24h. As a preferred solution, after the reaction is completed, add water to quench the reaction, separate and dry the organic phase solvent, and then purify the cyanostilbene structural monomer by column chromatography; the fourth organic solvent is chloroform;

所述第三制备方法中各步骤的反应条件包括如下:The reaction conditions of each step in the third preparation method include the following:

步骤(1)中:所述化合物Ⅹ与NBS的摩尔比为1:1-3,所述接触反应的温度为0-40℃,时间为1-5h;In step (1): the molar ratio of the compound X to NBS is 1:1-3, the temperature of the contact reaction is 0-40°C, and the time is 1-5h;

步骤(2)中:所述化合物Ⅺ、化合物Ⅻ和第二催化剂的摩尔比为1:1-3:0.1-1,Na2CO3水溶液质量分数为10-30%;In step (2): the molar ratio of the compound XI, the compound XII and the second catalyst is 1:1-3:0.1-1, and the mass fraction of the Na 2 CO 3 aqueous solution is 10-30%;

步骤(3)中:所述第一碱性调节剂为无水碳酸钾,所述第一催化剂为碘化钾,所述化合物ⅩⅢ、化合物Ⅱ、无水碳酸钾和碘化钾的摩尔比为1:3-10:3-10:0.1-1,所述第二有机溶剂为极性有机溶剂,所述接触反应的温度为30-80℃,时间为12-24h;In step (3): the first alkaline regulator is anhydrous potassium carbonate, the first catalyst is potassium iodide, and the mol ratio of the compound XIII, compound II, anhydrous potassium carbonate and potassium iodide is 1:3- 10:3-10:0.1-1, the second organic solvent is a polar organic solvent, the temperature of the contact reaction is 30-80°C, and the time is 12-24h;

步骤(4)中:所述第二碱性调节剂为叔丁醇钾;所述化合物ⅩⅣ、化合物IV与叔丁醇钾的摩尔比为2-4:1:0.2-1,所述接触反应的温度为30-80℃,时间为2-8h;In step (4): the second alkaline regulator is potassium tert-butoxide; the molar ratio of compound XIV, compound IV and potassium tert-butoxide is 2-4:1:0.2-1, and the contact reaction The temperature is 30-80℃, and the time is 2-8h;

步骤(5)中:所述缚酸剂为三乙胺;所述化合物ⅩⅦ与丙烯酰氯的摩尔比为1:3-4:3-5,所述接触反应的温度为0-40℃,时间为12-24h。In step (5): the acid binding agent is triethylamine; the molar ratio of the compound XVII to acryloyl chloride is 1:3-4:3-5, the temperature of the contact reaction is 0-40°C, and the time 12-24h.

根据本发明,优选地,所述二芳基乙烯化合物具有如通式Ⅳ所示的结构,且为开环或闭环结构;其中,X1、X2各自独立的选自R5、R6、R7、R8、R9或R10所示的结构基团,X1、X2相同或不同;According to the present invention, preferably, the diarylethene compound has the structure shown in the general formula IV, and is an open or closed ring structure; wherein, X 1 and X 2 are each independently selected from R 5 , R 6 , In the structural group represented by R 7 , R 8 , R 9 or R 10 , X 1 and X 2 are the same or different;

Figure BDA0001766389860000151
Figure BDA0001766389860000151

根据本发明,优选地,所述二芳基乙烯化合物选自具有通式b-1、b-2、b-3、b-4、b-5所示结构的二芳基乙烯化合物中的一种或多种;且以下各通式结构为开环或闭环结构。According to the present invention, preferably, the diarylethene compound is selected from one of the diarylethene compounds having the structures represented by the general formulas b-1, b-2, b-3, b-4, and b-5. one or more; and the following general structures are open-loop or closed-loop structures.

Figure BDA0001766389860000152
Figure BDA0001766389860000152

Figure BDA0001766389860000161
Figure BDA0001766389860000161

根据本发明,优选地,所述向列相液晶单体为C4M、C6M和C8M中的至少一种。According to the present invention, preferably, the nematic liquid crystal monomer is at least one of C4M, C6M and C8M.

根据本发明,优选地,可逆光调控荧光液晶纳米粒子的制备方法中:步骤(1)中:所述向列相液晶单体与氰芪结构单体的质量比为70-200:1;所述二芳基乙烯化合物与氰芪结构单体的质量比为1-9:1;所述第一有机溶剂为二氯甲烷和/或氯仿,第一有机溶剂与向列相液晶单体的质量比为2-10:1;According to the present invention, preferably, in the preparation method of reversible light-regulated fluorescent liquid crystal nanoparticles: in step (1): the mass ratio of the nematic liquid crystal monomer to the cyanostilbene structural monomer is 70-200:1; The mass ratio of the diarylethene compound to the cyanostilbene structural monomer is 1-9:1; the first organic solvent is dichloromethane and/or chloroform, and the mass ratio of the first organic solvent to the nematic liquid crystal monomer is The ratio is 2-10:1;

步骤(2)中:以所述氰芪结构单体和向列相液晶单体的混合物的总重量计,所述热引发剂的含量为0.1-2wt%,所述稳定剂的含量为1-10wt%,所述乳化剂的添加量为10-20wt%;水与所述第一有机溶剂体积比为30-50:1,所述乳化剂为十二烷基硫酸钠(SDS)或11-(丙烯酰氧基)十一酸钠(AC10COONa),所述热引发剂为偶氮二异丁腈(AIBN)、偶氮二异戊腈(AMBN)和过氧化苯甲酰(BPO)中的至少一种,所述稳定剂为十六烷醇(CA)、正十六烷(HD)、甲基丙烯酸十八酯(SMA)和丙烯酸十八酯(SA)中的至少一种,乳化时间为1-6h;In step (2): based on the total weight of the mixture of the cyanostilbene structural monomer and the nematic liquid crystal monomer, the content of the thermal initiator is 0.1-2 wt %, and the content of the stabilizer is 1-2 wt %. 10wt%, the added amount of the emulsifier is 10-20wt%; the volume ratio of water to the first organic solvent is 30-50:1, and the emulsifier is sodium dodecyl sulfate (SDS) or 11- (Acryloyloxy) sodium undecanoate (AC 10 COONa), the thermal initiators are azobisisobutyronitrile (AIBN), azobisisovaleronitrile (AMBN) and benzoyl peroxide (BPO) In at least one, the stabilizer is at least one of cetyl alcohol (CA), n-hexadecane (HD), stearyl methacrylate (SMA) and stearyl acrylate (SA), The emulsification time is 1-6h;

步骤(3)中:所述超声均质化的功率为120-450W,时间为5-30min;In step (3): the power of the ultrasonic homogenization is 120-450W, and the time is 5-30min;

步骤(4)中:所述加热聚合的温度为60-80℃,时间为12-24h。In step (4): the temperature of the heating polymerization is 60-80° C., and the time is 12-24 h.

本发明的另一方面提供一种可逆光调控彩色荧光墨水,以所述的可逆光调控彩色荧光墨水的总重量计,该可逆光调控彩色荧光墨水包括:3-10wt%的上述可逆光调控荧光液晶纳米粒子,2-6wt%的成膜剂,5-45wt%的水溶性有机溶剂,2-4wt%的乳化剂,0.1-2wt%的pH调节剂和0-70wt%的水,且各组分之和为100wt%。Another aspect of the present invention provides a reversible light-adjustable color fluorescent ink. Based on the total weight of the reversible light-adjustable color fluorescent ink, the reversible light-adjustable color fluorescent ink comprises: 3-10wt% of the above reversible light-adjustable fluorescent ink Liquid crystal nanoparticles, 2-6wt% film-forming agent, 5-45wt% water-soluble organic solvent, 2-4wt% emulsifier, 0.1-2wt% pH adjuster and 0-70wt% water, and each group The sum of the fractions is 100 wt%.

本发明的可逆光调控彩色荧光墨水能够通过喷墨打印的方法在纸张上写入信息,能够通过UV-Vis光交替照射实现写入信息的荧光影像从隐到显的变化,为打印文件文本内容等信息的重现、识别及可视化技术领域的应用提供重要参考价值。The reversible light-regulated color fluorescent ink of the present invention can write information on paper by an inkjet printing method, and can realize the change of the fluorescent image of the written information from hidden to obvious by alternately irradiating UV-Vis light, so as to print the text content of the document. It provides important reference value for the application in the field of reproduction, identification and visualization of information.

根据本发明,优选地,所述成膜剂为聚乙烯醇、水性聚氨酯,聚乙二醇、壳聚糖和明胶中的至少一种;所述水溶性有机溶剂为乙二醇、丙三醇、二乙二醇单甲醚,丙二醇甲醚和二丙二醇二甲醚中的至少一种;所述pH调节剂为氨水、NaHCO3、Na2CO3和三乙醇胺中的至少一种;所述乳化剂为十二烷基硫酸钠(SDS)、11-(丙烯酰氧基)十一酸钠(AC10COONa)和聚乙烯醇(PVA)中的至少一种。According to the present invention, preferably, the film-forming agent is at least one of polyvinyl alcohol, water-based polyurethane, polyethylene glycol, chitosan and gelatin; the water-soluble organic solvent is ethylene glycol, glycerol , at least one of diethylene glycol monomethyl ether, propylene glycol methyl ether and dipropylene glycol dimethyl ether; the pH regulator is at least one of ammonia water, NaHCO 3 , Na 2 CO 3 and triethanolamine; the The emulsifier is at least one of sodium dodecyl sulfate (SDS), 11-(acryloyloxy) sodium undecanoate (AC 10 COONa) and polyvinyl alcohol (PVA).

以下通过实施例进一步说明本发明:The present invention is further illustrated below by embodiment:

1.氰芪结构单体的制备:1. Preparation of cyanostilbene structural monomer:

制备例1Preparation Example 1

(1)取对羟基苯乙腈3g,6-溴己醇4.08g进行投料,再加入6.23无水碳酸钾和0.56g的碘化钾,在丙酮中60℃搅拌回流12h。应结束后进行减压抽滤,除去滤渣,旋蒸浓缩滤液,然后以氯仿:乙酸乙酯=3:1的体积比配制的混合溶液为溶剂进行色谱柱分离,得到化合物III;(1) Take 3 g of p-hydroxyphenylacetonitrile and 4.08 g of 6-bromohexanol for feeding, then add 6.23 g of anhydrous potassium carbonate and 0.56 g of potassium iodide, and stir and reflux in acetone at 60°C for 12 h. After finishing, carry out suction filtration under reduced pressure, remove the filter residue, concentrate the filtrate by rotary evaporation, and then use the mixed solution prepared in the volume ratio of chloroform:ethyl acetate=3:1 as a solvent to carry out chromatographic column separation to obtain compound III;

(2)化合物III 6.9g和2,5-二醛呋喃1.24g加入乙醇中搅拌,溶解后加入0.22g当量的叔丁醇钾,使体系呈强碱性,70℃下搅拌并回流4h,然后加入约1ml盐酸进行中和,使体系变为酸性,减压抽滤,并用乙醇清洗滤渣,将滤渣放置在真空烘箱中进行干燥,得到化合物V;(2) 6.9 g of compound III and 1.24 g of 2,5-dialdehyde furan were added to ethanol and stirred, and after dissolving, 0.22 g equivalent of potassium tert-butoxide was added to make the system strongly basic, stirred at 70° C. and refluxed for 4 h, then Add about 1ml of hydrochloric acid for neutralization to make the system acidic, filter under reduced pressure, and wash the filter residue with ethanol, and place the filter residue in a vacuum oven for drying to obtain compound V;

(3)将化合物V 5.5g、丙烯酰氯2.7g和三乙胺4.4g加入三氯甲烷中,然后移至常温环境下搅拌12h,反应完全后加入50ml水淬灭反应,用分液漏斗分液,取下层有机相,加入无水硫酸钠进行干燥,避光静置12h,旋蒸浓缩有机相,然后以三氯甲烷:乙酸乙酯=15:1的体积比配制的混合溶液为溶剂进行色谱柱分离,得到表1中化合物1所示结构的氰芪结构单体。(3) 5.5g of compound V, 2.7g of acryloyl chloride and 4.4g of triethylamine were added to chloroform, then moved to normal temperature and stirred for 12h, after the reaction was completed, 50ml of water was added to quench the reaction, and the liquid was separated with a separating funnel , remove the organic phase of the lower layer, add anhydrous sodium sulfate for drying, let stand in the dark for 12 hours, and concentrate the organic phase by rotary evaporation. Column separation to obtain the cyanostilbene structural monomer of the structure shown in compound 1 in Table 1.

制备例2Preparation Example 2

(1)取化合物Ⅰ的初始质量为3g,6-溴己醇4.08g进行投料,再加入6.23g无水碳酸钾和0.56g的碘化钾,在丙酮中60℃搅拌回流12h。反应结束后进行减压抽滤,除去滤渣,旋蒸浓缩滤液,然后以氯仿:乙酸乙酯=3:1的体积比配制的混合溶液为溶剂进行色谱柱分离,得到化合物III;(1) The initial mass of compound I was 3 g, 4.08 g of 6-bromohexanol was charged, 6.23 g of anhydrous potassium carbonate and 0.56 g of potassium iodide were added, and the mixture was stirred and refluxed in acetone at 60°C for 12 h. After the reaction is finished, carry out suction filtration under reduced pressure, remove the filter residue, and concentrate the filtrate by rotary evaporation, and then use the mixed solution prepared in the volume ratio of chloroform:ethyl acetate=3:1 as a solvent to carry out chromatographic column separation to obtain compound III;

(2)化合物III 6.9g和对苯二甲醛1.3g加入乙醇中搅拌,溶解后加入0.22g当量的叔丁醇钾,使体系呈强碱性,70℃下搅拌并回流4h,然后加入约1ml盐酸进行中和,使体系变为酸性,减压抽滤,并用乙醇清洗滤渣,将滤渣放置在真空烘箱中进行干燥,得到化合物V,其中,n为6;(2) 6.9 g of compound III and 1.3 g of terephthalaldehyde were added to ethanol and stirred, and after dissolving, 0.22 g equivalent of potassium tert-butoxide was added to make the system strongly alkaline, stirred at 70° C. and refluxed for 4 h, and then added about 1 ml The hydrochloric acid is neutralized to make the system acidic, vacuum filtration is performed, and the filter residue is washed with ethanol, and the filter residue is placed in a vacuum oven for drying to obtain compound V, wherein n is 6;

(3)将化合物V5.6g、丙烯酰氯2.7g和三乙胺4.4g加入三氯甲烷中,然后移至常温环境下搅拌12h,反应完全后加入50ml水淬灭反应,用分液漏斗分液,取下层有机相,加入无水硫酸钠进行干燥,避光静置12h,旋蒸浓缩有机相,然后以三氯甲烷:乙酸乙酯=15:1的体积比配制的混合溶液为溶剂进行色谱柱分离,得到表1中化合物2所示结构的氰芪结构单体。(3) 5.6 g of compound V, 2.7 g of acryloyl chloride and 4.4 g of triethylamine were added to chloroform, then moved to normal temperature and stirred for 12 h. After the reaction was completed, 50 ml of water was added to quench the reaction, and the liquid was separated with a separatory funnel. , remove the organic phase of the lower layer, add anhydrous sodium sulfate for drying, let stand in the dark for 12 hours, and concentrate the organic phase by rotary evaporation. Column separation to obtain the cyanostilbene structural monomer of the structure shown in compound 2 in Table 1.

制备例3Preparation Example 3

(1)将化合物Ⅵ2.0g、1-溴丙烷1.2g和0.24gNaH加入到二甲基亚砜中,室温下反应1h,反应结束后旋蒸浓缩,然后以氯仿:乙酸乙酯=3:1的体积比配制的混合溶液为溶剂进行色谱柱分离,得到化合物Ⅷ;(1) 2.0 g of compound VI, 1.2 g of 1-bromopropane and 0.24 g of NaH were added to dimethyl sulfoxide, reacted at room temperature for 1 h, concentrated by rotary evaporation after the reaction, and then mixed with chloroform:ethyl acetate=3:1 The mixed solution prepared in the volume ratio is the solvent for chromatographic column separation to obtain compound VIII;

(2)将化合物Ⅷ2.5g、无水DMF2.5g、POCl30.15g加入到二氯甲烷中,50℃下反应12h,反应结束后用水洗,旋蒸浓缩有机相,然后以氯仿:乙酸乙酯=3:1的体积比配制的混合溶液为溶剂进行色谱柱分离,得到化合物Ⅸ;(2) 2.5 g of compound VIII, 2.5 g of anhydrous DMF, and 0.15 g of POCl 3 were added to dichloromethane, reacted at 50° C. for 12 h, washed with water after the reaction, and the organic phase was concentrated by rotary evaporation, and then mixed with chloroform:ethyl acetate The mixed solution prepared with the volume ratio of ester=3:1 is used as the solvent to carry out chromatographic column separation to obtain compound IX;

(3)将化合物Ⅹ1.23g与NBS1.8g在DMF中室温下反应3h,反应结束后用水洗并用二氯甲烷萃取,旋蒸浓缩有机相,用二氯甲烷为溶剂进行色谱柱分离,得到化合物Ⅺ;(3) 1.23 g of compound X and 1.8 g of NBS were reacted in DMF at room temperature for 3 h, washed with water and extracted with dichloromethane after the reaction, the organic phase was concentrated by rotary evaporation, and the chromatographic column was separated by using dichloromethane as a solvent to obtain the compound Ⅺ;

(4)化合物Ⅺ2g、化合物Ⅻ1.4g、四三苯基膦钯0.9g加入到THF、甲醇和NaCO3水溶液的混合溶液中,80℃度下反应24h,结束反应后产物用水洗并用乙酸乙酯萃取,浓缩后用以二氯甲烷:乙酸乙酯=1:2的体积比配制的混合溶液为溶剂进行色谱柱分离,得到得到ⅩⅢ;(4) Compound XI 2g, compound XII 1.4g, tetrakistriphenylphosphine palladium 0.9g were added to the mixed solution of THF, methanol and NaCO 3 aqueous solution, and reacted at 80°C for 24h. After the reaction was completed, the product was washed with water and washed with ethyl acetate. Extraction, after concentrating, use the mixed solution prepared by the volume ratio of dichloromethane:ethyl acetate=1:2 as solvent to carry out chromatographic column separation to obtain XIII;

(5)取化合物ⅩⅢ2.2g,6-溴己醇1.8g进行投料,再加入2.8g无水碳酸钾和0.33g的碘化钾,在丙酮中60℃搅拌回流12h。应结束后进行减压抽滤,除去滤渣,旋蒸浓缩滤液,然后以氯仿:乙酸乙酯=3:1的体积比配制的混合溶液为溶剂进行色谱柱分离,得到化合物ⅩⅣ;(5) Take 2.2 g of compound XIII and 1.8 g of 6-bromohexanol for feeding, then add 2.8 g of anhydrous potassium carbonate and 0.33 g of potassium iodide, and stir and reflux in acetone at 60 °C for 12 h. After finishing, carry out suction filtration under reduced pressure, remove the filter residue, concentrate the filtrate by rotary evaporation, then use the mixed solution prepared in the volume ratio of chloroform:ethyl acetate=3:1 as a solvent to carry out chromatographic column separation to obtain compound XIV;

(6)化合物ⅩⅣ6.3g和化合物Ⅸ3.0g加入乙醇中搅拌,溶解后加入0.22g的叔丁醇钾,使体系呈强碱性,70℃下搅拌并回流4h,然后加入约1ml盐酸进行中和,使体系变为酸性,减压抽滤,并用乙醇清洗滤渣,将滤渣放置在真空烘箱中进行干燥,得到化合物ⅩⅤ;(6) 6.3 g of compound XIV and 3.0 g of compound IX were added to ethanol and stirred. After dissolving, 0.22 g of potassium tert-butoxide was added to make the system strongly alkaline. The system was stirred and refluxed at 70°C for 4 h, and then about 1 ml of hydrochloric acid was added to carry out the process. and, make the system acidic, filter under reduced pressure, and wash the filter residue with ethanol, and place the filter residue in a vacuum oven for drying to obtain compound XV;

(7)将化合物ⅩⅤ4.4g、丙烯酰氯0.9g和三乙胺1.5g加入三氯甲烷中,然后移至常温环境下搅拌12h,反应完全后加入50ml水淬灭反应,用分液漏斗分液,取下层有机相,加入无水硫酸钠进行干燥,避光静置12h,旋蒸浓缩有机相,然后以三氯甲烷:乙酸乙酯=15:1的体积比配制的混合溶液为溶剂进行色谱柱分离,得到表1中化合物3所示结构的氰芪结构单体。(7) 4.4 g of compound XV, 0.9 g of acryloyl chloride and 1.5 g of triethylamine were added to chloroform, then moved to normal temperature and stirred for 12 h. After the reaction was completed, 50 ml of water was added to quench the reaction, and the liquid was separated with a separatory funnel. , remove the organic phase of the lower layer, add anhydrous sodium sulfate for drying, let stand in the dark for 12 hours, and concentrate the organic phase by rotary evaporation. Column separation to obtain the cyanostilbene structural monomer of the structure shown in compound 3 in Table 1.

表1Table 1

Figure BDA0001766389860000201
Figure BDA0001766389860000201

2、可逆光调控荧光纳米粒子的制备:2. Preparation of reversible light-regulated fluorescent nanoparticles:

实施例1Example 1

(1)0.1g C6M、0.001g氰芪结构单体(表1中的化合物1)与BTE(b-3所示结构)0.005g共计0.106g原料进行混合,然后加入300μl三氯甲烷对其充分溶解,得到液晶混合物;(1) 0.1 g of C6M, 0.001 g of cyanostilbene structural monomer (compound 1 in Table 1) and 0.005 g of BTE (structure shown in b-3), a total of 0.106 g of raw materials were mixed, and then 300 μl of chloroform was added to make it fully Dissolved to obtain a liquid crystal mixture;

(2)在液晶混合物中加入0.0018g热引发剂AIBN和0.005g稳定剂丙烯酸十八酯充分混合得到油相;10ml去离子水中加入乳化剂AC10COONa0.02g充分混合得到水相,在磁力搅拌的同时将油相逐滴滴入水相,室温下搅拌3h进行乳化,得到水包油结构的粗乳液;(2) Add 0.0018g thermal initiator AIBN and 0.005g stabilizer stearyl acrylate to the liquid crystal mixture and mix well to obtain an oil phase; add 0.02g emulsifier AC10COONa to 10ml deionized water and mix well to obtain a water phase, while magnetic stirring The oil phase was dropped into the water phase dropwise, and stirred at room temperature for 3 hours to emulsify to obtain a crude emulsion with an oil-in-water structure;

(3)将粗乳液在超声细胞破碎仪中,冰浴条件下功率为400w超声15min进行均质化,得到细乳液;(3) homogenize the crude emulsion in an ultrasonic cell disruptor with a power of 400w ultrasonic for 15min under ice bath conditions to obtain a fine emulsion;

(4)将细乳液放入三口烧瓶中,在通N2、通水冷凝的同时搅拌15min除氧,然后70℃下水溶液水浴加热,一定搅拌速度下搅拌反应24小时,即得到可逆光调控荧光液晶纳米粒子。(4) Put the mini-emulsion into a three-necked flask, stir for 15 minutes while condensing through N2 and water to remove oxygen, then heat the aqueous solution in a water bath at 70°C, and stir for 24 hours at a certain stirring speed to obtain a reversible light-regulated fluorescent liquid crystal Nanoparticles.

3、可逆光调控彩色荧光墨水的制备:3. Preparation of reversible light-regulated color fluorescent ink:

实施例2Example 2

本实施例提供一种可逆光调控彩色荧光墨水,具体制备方法如下:The present embodiment provides a reversible light-regulated color fluorescent ink, and the specific preparation method is as follows:

(1)将实施例1制备得到的绿色的可逆光调控荧光液晶纳米粒子在真空烘箱中干燥得到干燥的绿色荧光染料;(1) drying the green reversible light-regulated fluorescent liquid crystal nanoparticles prepared in Example 1 in a vacuum oven to obtain a dry green fluorescent dye;

(2)称取干燥绿色荧光染料5.0g、质量浓度为5wt%的聚乙烯醇水溶液100g、丙三醇30g和AC10COONa 3.5g在搅拌桨3000r/min下搅拌20min;(2) weighing 5.0 g of dry green fluorescent dye, 100 g of a polyvinyl alcohol aqueous solution with a mass concentration of 5 wt%, 30 g of glycerol and 3.5 g of AC10COONa and stirred at 3000 r/min with a stirring paddle for 20 min;

(3)加入0.8gNa2HCO3调节PH值至8.4,得到可逆光调控彩色荧光墨水。(3) 0.8g Na 2 HCO 3 was added to adjust the pH value to 8.4 to obtain a reversible light-adjustable color fluorescent ink.

测试例1Test Example 1

对实施例1制备的可逆光调控荧光液晶纳米粒子进行电镜扫描。Electron microscope scanning was performed on the reversible light-regulated fluorescent liquid crystal nanoparticles prepared in Example 1.

如图1所示,可看到明显的球形结构,说明氰芪结构单体、二芳基乙烯化合物和向列相液晶单体的组合物被包入了纳米粒子中。As shown in Fig. 1, an obvious spherical structure can be seen, indicating that the composition of the cyanostilbene structural monomer, the diarylene compound and the nematic liquid crystal monomer is encapsulated in the nanoparticles.

测试例2Test case 2

将实施例1制备的可逆光调控荧光荧光液晶纳米粒子在功率为2mW的波长为365nm的UV灯和可见光照下照射,观察荧光强度的变化。The reversible light-regulated fluorescent fluorescent liquid crystal nanoparticles prepared in Example 1 were irradiated under a UV lamp with a power of 2 mW and a wavelength of 365 nm and visible light, and the change in the fluorescence intensity was observed.

如图2a所示,本发明的可逆光调控荧光液晶纳米粒子在功率为2mW的波长为365nm的UV灯照射下,荧光强度减弱,30s后达到稳定值;如图2b所示,本发明的可逆光调控荧光液晶纳米粒子在可见光光源照射下,荧光强度回复,110s后达到稳定值,如图3所示,在多次紫外-可见光的交替照射下,荧光强度可发生可逆变化。As shown in Figure 2a, when the reversible light-regulated fluorescent liquid crystal nanoparticles of the present invention are irradiated by a UV lamp with a power of 2mW and a wavelength of 365nm, the fluorescence intensity is weakened, and reaches a stable value after 30s; Under the irradiation of visible light source, the fluorescence intensity of the backlight-controlled fluorescent liquid crystal nanoparticles recovered and reached a stable value after 110 s.

测试例3Test case 3

将实施例2制备的可逆光调控彩色荧光墨水用EPSON-L383墨仓式打印图案,得到如图4(左)的图案;将得到的图案在2mW的波长为365nm的紫外(UV)灯下照射30s,荧光强度减弱得到如图4(右)的图案;再将图案在可见光下照射110s荧光强度回复,得到如图4(左)的图案;由此可见本发明的荧光墨水的荧光强度能够发生可逆变化,可实现可逆光调控。The reversible light-regulated color fluorescent ink prepared in Example 2 was printed with EPSON-L383 ink tank type to obtain the pattern as shown in Figure 4 (left); the obtained pattern was irradiated under an ultraviolet (UV) lamp with a wavelength of 365nm at 2mW. 30s, the fluorescence intensity is weakened to obtain the pattern as shown in Figure 4 (right); then the pattern is irradiated under visible light for 110s to recover the fluorescence intensity to obtain the pattern as shown in Figure 4 (left); it can be seen that the fluorescence intensity of the fluorescent ink of the present invention can generate Reversible changes, enabling reversible photoregulation.

以上已经描述了本发明的各实施例,上述说明是示例性的,并非穷尽性的,并且也不限于所披露的各实施例。在不偏离所说明的各实施例的范围和精神的情况下,对于本技术领域的普通技术人员来说许多修改和变更都是显而易见的。Various embodiments of the present invention have been described above, and the foregoing descriptions are exemplary, not exhaustive, and not limiting of the disclosed embodiments. Numerous modifications and variations will be apparent to those of ordinary skill in the art without departing from the scope and spirit of the described embodiments.

Claims (10)

1.一种可逆光调控荧光液晶纳米粒子,其特征在于,该可逆光调控荧光液晶纳米粒子通过细乳液聚合法制得,具体包括如下步骤:1. a reversible light-regulated fluorescent liquid crystal nanoparticle, is characterized in that, this reversible light-regulated fluorescent liquid crystal nanoparticle is obtained by miniemulsion polymerization method, specifically comprises the steps: (1)在第一有机溶剂的存在下,将氰芪结构单体、向列相液晶单体和二芳基乙烯类化合物混合均匀,得到液晶混合物;(1) in the presence of the first organic solvent, uniformly mixing the cyanostilbene structural monomer, the nematic liquid crystal monomer and the diarylethene compound to obtain a liquid crystal mixture; (2)将热引发剂、稳定剂和所述液晶混合物混合得到油相,将乳化剂和水混合得到水相,将油相和水相进行混合乳化,得到粗乳液;(2) mixing the thermal initiator, the stabilizer and the liquid crystal mixture to obtain an oil phase, mixing an emulsifier and water to obtain a water phase, and mixing and emulsifying the oil phase and the water phase to obtain a coarse emulsion; (3)将所述粗乳液进行超声均质化,得到细乳液;(3) ultrasonically homogenizing the coarse emulsion to obtain a fine emulsion; (4)在保护气体存在下,将所述细乳液除氧后进行加热聚合,得到可逆光调控荧光液晶纳米粒子;(4) in the presence of protective gas, deoxygenating the mini-emulsion and then performing heating and polymerization to obtain reversible light-regulated fluorescent liquid crystal nanoparticles; 其中,所述氰芪结构单体如通式I所示,M1为R1、R2、R3或R4所示的基团,M2选自通式II或通式III所示的基团,n为1-9的整数;Wherein, the cyanostilbene structural monomer is shown in general formula I, M 1 is a group represented by R 1 , R 2 , R 3 or R 4 , and M 2 is selected from general formula II or general formula III. group, n is an integer of 1-9;
Figure 2
Figure 2
.
2.根据权利要求1所述的可逆光调控荧光液晶纳米粒子,其中,所述氰芪结构单体选自具有通式a-1、a-2、a-3、a-4、a-5所示结构的氰芪结构化合物中的一种或多种,其中,n为1-9的整数;2. The reversible light-regulating fluorescent liquid crystal nanoparticle according to claim 1, wherein the cyanostilbene structural monomer is selected from the group consisting of formula a-1, a-2, a-3, a-4, a-5 One or more of the cyanostilbene structure compounds of the structure shown, wherein, n is an integer of 1-9;
Figure FDA0001766389850000021
Figure FDA0001766389850000021
Figure FDA0001766389850000031
Figure FDA0001766389850000031
3.根据权利要求1或2所述的可逆光调控荧光液晶纳米粒子,其中,所述氰芪结构单体的制备方法选自第一制备方法或第二制备方法;3. The reversible light-regulated fluorescent liquid crystal nanoparticle according to claim 1 or 2, wherein the preparation method of the cyanostilbene structural monomer is selected from the first preparation method or the second preparation method; 其中,所述第一制备方法包括如下步骤:Wherein, the first preparation method comprises the following steps: (1)在第二有机溶剂、第一碱性调节剂和第一催化剂的存在下,将化合物Ⅰ和化合物Ⅱ进行接触反应,得到化合物III;(1) in the presence of the second organic solvent, the first basic regulator and the first catalyst, the compound I and the compound II are subjected to a contact reaction to obtain the compound III; (2)在第三有机溶剂和第二碱性调节剂的存在下,将所述化合物III和化合物Ⅳ进行接触反应,蒸除溶剂后得到化合物V;(2) in the presence of the third organic solvent and the second basic regulator, the compound III and the compound IV are subjected to a contact reaction, and the compound V is obtained after the solvent is evaporated; (3)在第四有机溶剂和缚酸剂存在下,将所述化合物V和丙烯酰氯进行接触反应,制得所述氰芪结构单体;(3) in the presence of a fourth organic solvent and an acid binding agent, the compound V and acryloyl chloride are subjected to a contact reaction to obtain the cyanostilbene structural monomer; 所述第二制备方法包括如下步骤:The second preparation method comprises the following steps: (1)在第五有机溶剂和第三碱性调节剂存在下,将所述化合物Ⅵ和化合物Ⅶ进行接触反应,得到化合物Ⅷ;(1) in the presence of the fifth organic solvent and the third basic regulator, the compound VI and the compound VII are subjected to a contact reaction to obtain the compound VIII; (2)在第六有机溶剂和第二催化剂存在下,将所述化合物Ⅷ和DMF进行接触反应,得到化合物Ⅸ;(2) in the presence of the sixth organic solvent and the second catalyst, the compound VIII and DMF are subjected to a contact reaction to obtain compound IX; (3)在第七有机溶剂存在下,将所述化合物Ⅹ与NBS进行接触反应,得到化合物Ⅺ;(3) in the presence of the seventh organic solvent, the compound X is contacted and reacted with NBS to obtain compound XI; (4)在第八有机溶剂、第九有机溶剂、第三催化剂和Na2CO3水溶液存在下,将所述化合物Ⅺ和化合物Ⅻ进行接触反应,得到化合物ⅩⅢ;(4) in the presence of the eighth organic solvent, the ninth organic solvent, the third catalyst and the Na 2 CO 3 aqueous solution, the compound XI and the compound XII are subjected to a contact reaction to obtain the compound XIII; (5)在第二有机溶剂、第一碱性调节剂和第一催化剂的存在下,将化合物ⅩⅢ和化合物Ⅱ进行接触反应,得到化合物ⅩⅣ;(5) in the presence of the second organic solvent, the first basic regulator and the first catalyst, the compound XIII and the compound II are subjected to a contact reaction to obtain the compound XIV; (6)在第三有机溶剂和第二碱性调节剂存在下,将所述化合物ⅩⅣ和化合物Ⅸ进行接触反应,蒸除溶剂后得到化合物ⅩⅤ;(6) in the presence of the third organic solvent and the second basic regulator, the compound XIV and the compound IX are subjected to a contact reaction, and the compound XV is obtained after the solvent is evaporated; (7)在第四有机溶剂和缚酸剂存在下,将所述化合物ⅩⅤ和丙烯酰氯进行接触反应,制得所述氰芪结构单体。(7) In the presence of a fourth organic solvent and an acid binding agent, the compound XV and acryloyl chloride are subjected to a contact reaction to obtain the cyanostilbene structural monomer. 其中,所述化合物Ⅰ的结构式为:Wherein, the structural formula of the compound I is:
Figure FDA0001766389850000041
Figure FDA0001766389850000041
所述化合物II的结构式为:The structural formula of the compound II is:
Figure FDA0001766389850000042
式中,n为1-9的整数,X选自溴原子或碘原子;
Figure FDA0001766389850000042
In the formula, n is an integer of 1-9, and X is selected from a bromine atom or an iodine atom;
所述化合物III的结构式为The structural formula of the compound III is
Figure FDA0001766389850000043
式中,n为1-9的整数;
Figure FDA0001766389850000043
In the formula, n is an integer from 1 to 9;
所述化合物IV的结构式为:The structural formula of the compound IV is:
Figure FDA0001766389850000044
其中,R选自所述R1、R2、R3或R4所示的结构基团,
Figure FDA0001766389850000044
wherein, R is selected from the structural groups represented by the R 1 , R 2 , R 3 or R 4 ,
所述化合物V的结构式为:The structural formula of the compound V is:
Figure FDA0001766389850000045
式中,n为1-9的整数;
Figure FDA0001766389850000045
In the formula, n is an integer from 1 to 9;
所述化合物Ⅵ的结构式为:
Figure FDA0001766389850000046
The structural formula of the compound VI is:
Figure FDA0001766389850000046
所述化合物Ⅶ的结构式为:
Figure FDA0001766389850000051
The structural formula of the compound VII is:
Figure FDA0001766389850000051
所述化合物Ⅷ的结构式为: The structural formula of the compound VIII is: 所述化合物Ⅸ的结构式为: The structural formula of the compound IX is: 所述化合物Ⅹ的结构式为:
Figure FDA0001766389850000054
The structural formula of the compound X is:
Figure FDA0001766389850000054
所述化合物Ⅺ的结构式为:
Figure FDA0001766389850000055
The structural formula of the compound XI is:
Figure FDA0001766389850000055
所述化合物Ⅻ的结构式为:
Figure FDA0001766389850000056
The structural formula of the compound XII is:
Figure FDA0001766389850000056
所述化合物ⅩⅢ的结构式为:
Figure FDA0001766389850000057
The structural formula of the compound XIII is:
Figure FDA0001766389850000057
所述化合物ⅩⅣ的结构式为:
Figure FDA0001766389850000061
式中,n为1-9的整数;
The structural formula of the compound XIV is:
Figure FDA0001766389850000061
In the formula, n is an integer from 1 to 9;
所述化合物ⅩⅤ的结构式为:The structural formula of the compound XV is:
Figure FDA0001766389850000062
Figure FDA0001766389850000062
式中,n为1-9的整数。In the formula, n is an integer of 1-9.
4.根据权利要求3所述的可逆光调控荧光液晶纳米粒子,其中,4. The reversible light-regulated fluorescent liquid crystal nanoparticle according to claim 3, wherein, 所述第一制备方法中各步骤的反应条件包括如下:The reaction conditions of each step in the first preparation method include the following: 步骤(1)中:所述第一碱性调节剂为无水碳酸钾,所述第一催化剂为碘化钾;所述化合物Ⅰ、化合物Ⅱ、无水碳酸钾和碘化钾的摩尔比为1:3-10:3-10:0.1-1,所述第二有机溶剂为极性有机溶剂,所述接触反应的温度为30-80℃,时间为12-24h;In step (1): the first alkaline regulator is anhydrous potassium carbonate, and the first catalyst is potassium iodide; the mol ratio of the compound I, compound II, anhydrous potassium carbonate and potassium iodide is 1:3- 10:3-10:0.1-1, the second organic solvent is a polar organic solvent, the temperature of the contact reaction is 30-80°C, and the time is 12-24h; 步骤(2)中:所述第二碱性调节剂为叔丁醇钾;所述化合物III、化合物Ⅳ与叔丁醇钾的摩尔比为2-3:1:0.1-0.5,所述接触反应的温度为30-80℃,时间为2-8h;In step (2): the second alkaline regulator is potassium tert-butoxide; the molar ratio of compound III, compound IV and potassium tert-butoxide is 2-3:1:0.1-0.5, and the contact reaction The temperature is 30-80℃, and the time is 2-8h; 步骤(3)中:所述缚酸剂为三乙胺;所述化合物V、丙烯酰氯和三乙胺的摩尔比为1:3-4:3-5,所述接触反应的温度为0-40℃,时间为12-24h;In step (3): the acid binding agent is triethylamine; the molar ratio of the compound V, acryloyl chloride and triethylamine is 1:3-4:3-5, and the temperature of the contact reaction is 0- 40℃, the time is 12-24h; 所述第二制备方法中各步骤的反应条件包括如下:The reaction conditions of each step in the second preparation method include the following: 步骤(1)中:所述第三碱性调节剂为NaH或者NaOH;所述化合物Ⅵ、化合物Ⅶ和所述第三碱性调节剂的摩尔比为1:1-3:1-10,所述接触反应的温度为0-40℃,时间为1-2小时;In step (1): the third alkaline regulator is NaH or NaOH; the molar ratio of the compound VI, the compound VII and the third alkaline regulator is 1:1-3:1-10, so the The temperature of the contact reaction is 0-40 ° C, and the time is 1-2 hours; 步骤(2)中:所述化合物Ⅷ、DMF和第二催化剂的摩尔比为1:2-5:0.1-1所述第一催化剂为POCl3,所述接触反应的温度为30-70℃,时间为12-24h;In step (2): the molar ratio of the compound VIII, DMF and the second catalyst is 1:2-5:0.1-1, the first catalyst is POCl , the temperature of the contact reaction is 30-70 ° C, and the time for 12-24h; 步骤(3)中:所述化合物Ⅹ与NBS的摩尔比为1:1-3,所述接触反应的温度为0-40℃,时间为1-5h;In step (3): the molar ratio of the compound X to NBS is 1:1-3, the temperature of the contact reaction is 0-40°C, and the time is 1-5h; 步骤(4)中:所述化合物Ⅺ、化合物Ⅻ和第三催化剂的摩尔比为1:1-3:0.1-1,所述Na2CO3水溶液的质量分数为10-30%;In step (4): the molar ratio of the compound XI, the compound XII and the third catalyst is 1:1-3:0.1-1, and the mass fraction of the Na 2 CO 3 aqueous solution is 10-30%; 步骤(5)包括:所述第一碱性调节剂为无水碳酸钾,所述第一催化剂为碘化钾;化合物ⅩⅢ、化合物Ⅱ、无水碳酸钾和碘化钾的摩尔比为1:3-10:3-10:0.1-1,所述第二有机溶剂为极性有机溶剂,所述接触反应的温度为30-80℃,时间为12-24h;Step (5) includes: the first alkaline regulator is anhydrous potassium carbonate, and the first catalyst is potassium iodide; the mol ratio of compound XIII, compound II, anhydrous potassium carbonate and potassium iodide is 1:3-10: 3-10: 0.1-1, the second organic solvent is a polar organic solvent, the temperature of the contact reaction is 30-80°C, and the time is 12-24h; 步骤(6)包括:所述第二碱性调节剂为叔丁醇钾;所述化合物ⅩⅣ、化合物Ⅸ与叔丁醇钾的摩尔比2-4:1:0.2-1,所述接触反应的温度为30-80℃,时间为2-8小时;Step (6) includes: the second alkaline regulator is potassium tert-butoxide; the molar ratio of compound XIV, compound IX and potassium tert-butoxide is 2-4:1:0.2-1, and the contact reaction is 2-4:1:0.2-1. The temperature is 30-80℃, and the time is 2-8 hours; 步骤(7)包括:所述缚酸剂为三乙胺;所述化合物ⅩⅤ、丙烯酰氯和三乙胺的摩尔比为1:3-4:3-5,所述接触反应的温度为0-40℃,时间为12-24h。Step (7) includes: the acid binding agent is triethylamine; the molar ratio of the compound XV, acryloyl chloride and triethylamine is 1:3-4:3-5, and the temperature of the contact reaction is 0- 40℃, the time is 12-24h. 5.根据权利要求1所述的可逆光调控荧光液晶纳米粒子,其中,所述二芳基乙烯化合物具有如通式Ⅳ所示的结构;其中,X1、X2各自独立的选自R5、R6、R7、R8、R9或R10所示的结构基团,X1、X2相同或不同;5. The reversible light-adjustable fluorescent liquid crystal nanoparticle according to claim 1, wherein the diarylethene compound has a structure as shown in general formula IV; wherein, X 1 and X 2 are each independently selected from R 5 , R 6 , R 7 , R 8 , R 9 or R 10 represented by the structural group, X 1 , X 2 are the same or different;
Figure FDA0001766389850000081
Figure FDA0001766389850000081
6.根据权利要求1所述的可逆光调控荧光液晶纳米粒子,其中,所述二芳基乙烯化合物选自具有通式b-1、b-2、b-3、b-4、b-5所示结构的二芳基乙烯化合物中的一种或多种;6. The reversible light-adjustable fluorescent liquid crystal nanoparticle according to claim 1, wherein the diarylethene compound is selected from the group consisting of formulas b-1, b-2, b-3, b-4, b-5 One or more of the diarylethene compounds of the structure shown;
Figure FDA0001766389850000082
Figure FDA0001766389850000082
Figure FDA0001766389850000091
Figure FDA0001766389850000091
7.根据权利要求1所述的可逆光调控荧光液晶纳米粒子,其中,所述向列相液晶单体为C4M、C6M和C8M中的至少一种。7 . The reversible light-adjustable fluorescent liquid crystal nanoparticles according to claim 1 , wherein the nematic liquid crystal monomer is at least one of C4M, C6M and C8M. 8 . 8.根据权利要求1所述的可逆光调控荧光液晶纳米粒子,其中,8. The reversible light-regulating fluorescent liquid crystal nanoparticle according to claim 1, wherein, 步骤(1)中:所述向列相液晶单体与氰芪结构单体的质量比为70-200:1;所述二芳基乙烯化合物与氰芪结构单体的质量比为1-9:1;所述第一有机溶剂为二氯甲烷和/或氯仿,第一有机溶剂与向列相液晶单体的质量比为2-10:1;In step (1): the mass ratio of the nematic liquid crystal monomer to the cyanostilbene structural monomer is 70-200:1; the mass ratio of the diarylene compound to the cyanostilbene structural monomer is 1-9 : 1; the first organic solvent is dichloromethane and/or chloroform, and the mass ratio of the first organic solvent to the nematic liquid crystal monomer is 2-10:1; 步骤(2)中:以所述氰芪结构单体和向列相液晶单体的混合物的总重量计,所述热引发剂的含量为0.1-2wt%,所述稳定剂的含量为1-10wt%,所述乳化剂的添加量为10-20wt%;水与所述第一有机溶剂体积比为30-50:1,所述乳化剂为十二烷基硫酸钠或11-(丙烯酰氧基)十一酸钠,所述热引发剂为偶氮二异丁腈、偶氮二异戊腈和过氧化苯甲酰中的至少一种,所述稳定剂为十六烷醇、正十六烷、甲基丙烯酸十八酯和丙烯酸十八酯中的至少一种,乳化时间为1-6h;In step (2): based on the total weight of the mixture of the cyanostilbene structural monomer and the nematic liquid crystal monomer, the content of the thermal initiator is 0.1-2 wt %, and the content of the stabilizer is 1-2 wt %. 10wt%, the added amount of the emulsifier is 10-20wt%; the volume ratio of water to the first organic solvent is 30-50:1, and the emulsifier is sodium lauryl sulfate or 11-(acryloyl oxy) sodium undecanoate, the thermal initiator is at least one of azobisisobutyronitrile, azobisisovaleronitrile and benzoyl peroxide, and the stabilizer is hexadecanol, normal At least one of hexadecane, stearyl methacrylate and stearyl acrylate, and the emulsification time is 1-6h; 步骤(3)中:所述超声均质化的功率为120-450W,时间为5-30min;In step (3): the power of the ultrasonic homogenization is 120-450W, and the time is 5-30min; 步骤(4)中:所述加热聚合的温度为60-80℃,时间为12-24h。In step (4): the temperature of the heating polymerization is 60-80° C., and the time is 12-24 h. 9.一种可逆光调控彩色荧光墨水,其特征在于,以所述的可逆光调控彩色荧光墨水的总重量计,该可逆光调控彩色荧光墨水包括:3-10wt%的权利要求1-8中任意一项所述的可逆光调控荧光液晶纳米粒子,2-6wt%的成膜剂,5-45wt%的水溶性有机溶剂,2-4wt%的乳化剂,0.1-2wt%的pH调节剂和0-70wt%的水,且各组分之和为100wt%。9. A reversible light-regulated color fluorescent ink, characterized in that, in terms of the total weight of the reversible light-regulated color fluorescent ink, the reversible light-regulated color fluorescent ink comprises: 3-10wt% in claims 1-8 Any one of the reversible light-regulated fluorescent liquid crystal nanoparticles, 2-6wt% of a film-forming agent, 5-45wt% of a water-soluble organic solvent, 2-4wt% of an emulsifier, 0.1-2wt% of a pH adjuster and 0-70 wt% water, and the sum of the components is 100 wt%. 10.根据权利要求9所述的可逆光调控彩色荧光墨水,其中,所述成膜剂为聚乙烯醇、水性聚氨酯,聚乙二醇、壳聚糖和明胶中的至少一种;所述水溶性有机溶剂为乙二醇、丙三醇、二乙二醇单甲醚,丙二醇甲醚和二丙二醇二甲醚中的至少一种;所述pH调节剂为氨水、NaHCO3、Na2CO3和三乙醇胺中的至少一种;所述乳化剂为十二烷基硫酸钠、11-(丙烯酰氧基)十一酸钠和聚乙烯醇中的至少一种。10. The reversible light-regulated color fluorescent ink according to claim 9, wherein the film-forming agent is at least one of polyvinyl alcohol, water-based polyurethane, polyethylene glycol, chitosan and gelatin; the water-soluble The organic solvent is at least one of ethylene glycol, glycerol, diethylene glycol monomethyl ether, propylene glycol methyl ether and dipropylene glycol dimethyl ether; the pH regulator is ammonia water, NaHCO , Na 2 CO 3 and At least one of triethanolamine; the emulsifier is at least one of sodium lauryl sulfate, 11-(acryloyloxy) sodium undecanoate and polyvinyl alcohol.
CN201810930147.9A 2018-08-15 2018-08-15 Reversible light modulation and control fluorescent liquid crystal nano particle and reversible light modulation and control color fluorescent ink Active CN110835530B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810930147.9A CN110835530B (en) 2018-08-15 2018-08-15 Reversible light modulation and control fluorescent liquid crystal nano particle and reversible light modulation and control color fluorescent ink

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810930147.9A CN110835530B (en) 2018-08-15 2018-08-15 Reversible light modulation and control fluorescent liquid crystal nano particle and reversible light modulation and control color fluorescent ink

Publications (2)

Publication Number Publication Date
CN110835530A true CN110835530A (en) 2020-02-25
CN110835530B CN110835530B (en) 2022-07-12

Family

ID=69574125

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810930147.9A Active CN110835530B (en) 2018-08-15 2018-08-15 Reversible light modulation and control fluorescent liquid crystal nano particle and reversible light modulation and control color fluorescent ink

Country Status (1)

Country Link
CN (1) CN110835530B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210116869A (en) * 2020-03-18 2021-09-28 한국화학연구원 Radical based mechanochromic monomers and self-reporting polymers

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104098555A (en) * 2014-07-15 2014-10-15 江西科技师范大学 Method for synthesizing ultrashort-wavelength photochromic diarylethene compound by using imidazole-thiophene aromatic heterocycle and application of compound
JP2015145450A (en) * 2014-01-31 2015-08-13 日東電工株式会社 Method for producing photoresponsive cross-linked liquid crystal polymer film and photoresponsive cross-linked liquid crystal polymer film obtained by the production method
CN106588866A (en) * 2016-11-21 2017-04-26 北京化工大学 Chiral fluorescence molecule optical switch, preparation method thereof, cholesteric phase liquid crystal composition, preparation method thereof, and liquid crystal display (LCD)

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015145450A (en) * 2014-01-31 2015-08-13 日東電工株式会社 Method for producing photoresponsive cross-linked liquid crystal polymer film and photoresponsive cross-linked liquid crystal polymer film obtained by the production method
CN104098555A (en) * 2014-07-15 2014-10-15 江西科技师范大学 Method for synthesizing ultrashort-wavelength photochromic diarylethene compound by using imidazole-thiophene aromatic heterocycle and application of compound
CN106588866A (en) * 2016-11-21 2017-04-26 北京化工大学 Chiral fluorescence molecule optical switch, preparation method thereof, cholesteric phase liquid crystal composition, preparation method thereof, and liquid crystal display (LCD)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JUNTAO LI ET AL.: "Dicyanodistyrylbenzene-Based Chiral Fluorescence Photoswitches: An Emerging Class of Multifunctional Switches for Dual-Mode Phototunable Liquid Crystals", 《ADVANCED OPTICAL MATERIALS》 *
ZHE-WEI ZHANG ET AL.: "A Luminescent Dicyanodistyrylbenzene-based Liquid Crystal Polymer Network for Photochemically Patterned Photonic Composite Film", 《CHINESE JOURNAL OF POLYMER SCIENCE》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210116869A (en) * 2020-03-18 2021-09-28 한국화학연구원 Radical based mechanochromic monomers and self-reporting polymers
KR102396554B1 (en) 2020-03-18 2022-05-10 한국화학연구원 Radical based mechanochromic monomers and self-reporting polymers

Also Published As

Publication number Publication date
CN110835530B (en) 2022-07-12

Similar Documents

Publication Publication Date Title
Luo et al. Photo‐responsive fluorescent materials with aggregation‐induced emission characteristics
Liu et al. Effect of decarboxylation on the photoinitiation behavior of nitrocarbazole-based oxime esters
Li et al. Synthesis and properties of photochromic spirooxazine with aggregation-induced emission fluorophores polymeric nanoparticles
CN102516988B (en) A kind of polymerizable fluorescent dye, its preparation method and application
CN103342657A (en) Azobenzene liquid crystal monomer, and synthetic method and application thereof
CN101812182A (en) Preparation method of photoelectric sensitive charged nanometer particles
Chen et al. One-pot synthesis of amphiphilic reversible photoswitchable fluorescent nanoparticles and their fluorescence modulation properties
Qi et al. High-efficient lignin-based polymerizable macromolecular photoinitiator with UV-blocking property for visible light polymerization
CN108558794A (en) A kind of preparation method for reacting synthesis light-sensitive compound according to Claisen-Schmidt
CN114702952B (en) Adjustable near infrared photosensitizer based on arene macrocycle with aggregation-induced luminescence column, preparation method and application thereof
CN113801299A (en) Fluorescent conjugated polymer containing spiropyran side group, preparation method and application
Huang et al. A polymerizable aggregation-induced emission dye for fluorescent nanoparticles: synthesis, molecular structure and application in cell imaging
CN110835530B (en) Reversible light modulation and control fluorescent liquid crystal nano particle and reversible light modulation and control color fluorescent ink
CN108558701B (en) A kind of small molecule AIEE light-emitting material with triple stimulus responsiveness and preparation method thereof
Jiang et al. Time-dependent multicolor afterglow from dual persistent luminescence of fluorescence and phosphorescence in a UV-cured polyurethane matrix
Li et al. A supramolecular polymeric photoinitiator with enhanced dispersion in photo-curing systems
CN107129451A (en) Novel belt cyano group diphenylethyllene sulfosalt preparation method and applications
Łyszczek et al. Hybrid materials based on PEGDMA matrix and europium (III) carboxylates-thermal and luminescent investigations
Deng et al. Polymeric nanoparticles based on CDs with photoreversible dual-color fluorescence modulation
CN106478843B (en) A kind of double oxime ester lightlike initiating agents containing thiphene ring and its preparation method and application
CN105111414A (en) Conjugated polymer containing fluorene as well as preparation method and application thereof
Huang et al. An acrylate AIE-active dye with a two-photon fluorescent switch for fluorescent nanoparticles by RAFT polymerization: synthesis, molecular structure and application in cell imaging
TW201441767A (en) Coloring composition, coloring cured film and display component
CN103193970A (en) Preparation method of hyperbranched fluorescent polymer
CN112342036A (en) Liquid crystal material combining structural color and fluorescence and liquid crystal device

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant